All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Liraglutide 1.2mg: Results Timeline

Liraglutide 1.2mg results timeline. Day-by-day expectations during the second week of treatment, early weight loss indicators, and what to track at...

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

Liraglutide 1.2mg: Results Timeline custom 2026 header image for GLP-1 Weight Loss
Custom header image for Liraglutide 1.2mg: Results Timeline, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Liraglutide 1.2mg: Results Timeline

Liraglutide 1.2mg results timeline. Day-by-day expectations during the second week of treatment, early weight loss indicators, and what to track at...

Short answer

Liraglutide 1.2mg results timeline. Day-by-day expectations during the second week of treatment, early weight loss indicators, and what to track at...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Liraglutide 1.2mg results timeline. Day-by-day expectations during the second week of treatment, early weight loss indicators, and what to track at this dose level.

At liraglutide 1.2mg, the second dose in the titration, most patients begin to notice appetite changes that were absent or subtle at 0.6mg. Weight loss during this one-week phase is typically 1 to 2 pounds. While still below the full therapeutic dose, 1.2mg provides the first tangible evidence that the medication is influencing your eating behavior. Steady-state blood levels at 1.2mg are reached within 2 to 3 days, and the full effect of this dose is present by mid-week.

Day-by-Day at 1.2mg

Day 1 (Treatment Day 8)
First injection at the higher dose. You may notice slightly stronger appetite suppression within hours, particularly if your previous dose was taken that morning and the combined residual effect is slightly improved during the transition.
Days 2 to 3
Steady-state blood levels at 1.2mg are approximately reached. If mild nausea is going to occur, this is the window. Appetite reduction becomes more consistent. You may find yourself naturally eating less at meals without conscious restriction.
Days 4 to 5
Adaptation is underway. Nausea (if present) has diminished. Eating patterns are shifting. Many patients notice that their portion sizes have decreased and they feel satisfied sooner. Snacking impulses may be weaker than before.
Days 6 to 7
The final days before increasing to 1.8mg. Your body has adapted to 1.2mg, and the effect feels stable. GI symptoms should be fully resolved. If they aren't, consider extending 1.2mg for an additional week.

Liraglutide 1.8mg what to expect

Weight Changes at 1.2mg

This is the phase where the scale may start to respond, though modestly:

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Liraglutide 1.2mg: Results Timeline
  • Most patients: 1 to 2 pounds lost during the week at 1.2mg
  • Some patients: No change, which is still normal
  • Cumulative (after 2 weeks of treatment): 1 to 4 pounds total from treatment start

The weight change at this dose is a blend of reduced food intake, slight water loss, and the very beginnings of fat reduction. True, sustained fat loss accelerates at 1.8mg and above.

Non-Scale Changes to Notice

Beyond weight, watch for these early indicators that the medication is working:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • Portion awareness: You naturally serve yourself less food or stop eating sooner
  • Reduced snacking: The urge to graze between meals diminishes
  • Food noise reduction: Less mental preoccupation with food, fewer cravings, easier to pass up treats
  • Slower eating pace: Some patients notice they eat more slowly because the sense of fullness arrives earlier
  • Better food choices: With reduced appetite, patients often find it easier to choose nutritious options over convenience foods

Document these changes in a journal. They matter more than the number on the scale during the titration phase, and they predict how well you'll respond at the full dose.

Comparing 1.2mg to Other GLP-1 Starting Phases

For context, here is how the liraglutide 1.2mg phase compares to the early phases of other GLP-1 medications:

Medication Week 2 Dose Typical Week 2 Weight Change
Liraglutide 1.2mg daily 0-2 lbs lost
Semaglutide (Wegovy) 0.25mg weekly 0-2 lbs lost
Tirzepatide (Mounjaro) 2.5mg weekly 1-3 lbs lost

All GLP-1 medications start slow. The early titration weeks are about preparation, not results.

Frequently Asked Questions

Should I judge liraglutide's effectiveness based on my 1.2mg results?
No. The 1.2mg dose is 40 percent of the target dose. Judging the medication now would be like evaluating a car's speed while still in first gear. Wait until you have been at 3.0mg for at least 4 weeks before assessing effectiveness. liraglutide 1.2mg how long to stay on
I lost 3 pounds at 1.2mg. Does that predict good results?
Early responders (those who lose more than average during titration) do tend to be above-average responders at the full dose. But patients who see minimal change during titration can still achieve excellent results at 3.0mg. Early results are encouraging but not definitive.
Can I exercise more aggressively at 1.2mg?
Yes. Continue or increase your exercise routine. At 1.2mg, most patients are eating enough to support moderate to vigorous exercise. Stay hydrated and listen to your body. If you experience dizziness during exercise, eat a small snack 30 to 60 minutes before your workout.
My appetite hasn't changed at all at 1.2mg. Is that a problem?
Not necessarily. Some patients don't feel significant appetite changes until 1.8mg or even 2.4mg. The response varies by individual. Continue the titration as planned. If you reach 3.0mg and still feel no appetite suppression after 4 weeks, discuss options with your prescriber.

This article is for informational purposes only and doesn't constitute medical advice. The 1.2mg phase is brief. Focus on building habits rather than judging results.

Contact provider for current pricing Contact provider for current pricing

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Mounjaro evidence source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Liraglutide 1.2mg: Results Timeline, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Liraglutide 1.2mg: Results Timeline research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Liraglutide 1.2mg results timeline. Day-by-day expectations during the second week of treatment, early weight loss indicators, and what to track at this dose level. Use "Liraglutide 1.2mg: Results Timeline" to make the conversation more specific before you choose a provider, product, or next step. The page leans into patient education and clinical context and the details behind dosing. Because this article has 5 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. The safest takeaway is a better checklist for clinician review, not a do-it-yourself medical decision.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Liraglutide 1.2mg

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, liraglutide, 2mg so the article stays close to the question behind "Liraglutide 1.2mg".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Liraglutide 1.2mg from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Liraglutide 1.2mg custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Liraglutide 1.2mg, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Liraglutide 1.2mg, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.